Amicus Therapeutics Inc is a global biotechnology company that aims to treat rare and orphan diseases. The company's strategy focuses on global capacity with an international infrastructure, late-stage product acquisition, and biologics manufacturing. Amicus leverages its pharmacological technology to develop treatments for human genetic diseases by targeting mutated proteins. The company utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products.
| Website: | www.amicusrx.com |
| Email: | info@amicusrx.co.uk |
| Main Phone: | +1 609 662-2000 |
| Address: | 1 Cedar Brook Drive |
| State: | NJ |
| City / Town: | Cranbury |
| Country: | USA |
| Postal Code: | 08512 |
| Exchange: | NSD |
| CEO: | John F. Crowley |
| Employees: | 325 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
| Last Price 10.51 | Change $ -0.01 | Change % -0.10 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask 11.10 | Ask Size 100.00 |
| Open 10.41 | High 10.77 | Low 10.38 | Prev Close 10.52 |
| Last Trade | Volume 1.2 mi | 52 Wk Hi 17.62 | 52 Wk Low 9.65 |
| Market Cap 2 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 189,289,881.00 | EPS (TTM) -1.86 | PE Ratio N/A | Exchange NSD |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 22 | 110 |
| Number of Buys | 13 | 61 |
| Number of Sells | 9 | 49 |
| Net Activity | -78433 | 2199222 |
| Last 10 Buys | Shares |
|---|---|
| Edelman Joseph | 1,000 |
| Edelman Joseph | 1,000 |
| Edelman Joseph | 1,000 |
| Edelman Joseph | 1,000 |
| Ellen S. Rosenberg | 1,000 |
| Margaret G. McGlynn | 1,000 |
| Edelman Joseph | 1,000 |
| Edelman Joseph | 1,000 |
| Edelman Joseph | 1,000 |
| Edelman Joseph | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Hung Do | 1,000 |
| Hung Do | 1,000 |
| Margaret G. McGlynn | 1,000 |
| Jay Barth | 1,000 |
| Hung Do | 1,000 |
| Michael G. Raab | 1,000 |
| Jay Barth | 1,000 |
| Kurt J. Andrews | 1,000 |
| William D. Baird | 1,000 |
| Jay Barth | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 22 | 22 | 22 | 22 |
| Low Target Price Estimate | 18.5 | 18.5 | 18.5 | 18.5 |
| Mean Target Price Estimate | 20.08 | 20.08 | 20.08 | 20.08 |
| Standard Deviation | 1.56 | 1.56 | 1.56 | 1.56 |
| Date of Most Recent Estimate | 05/11/18 | 05/11/18 | 05/11/18 | 05/11/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-11 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-11 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-11 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-11 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-11 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-11 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-11 |
| 8-K | Report of unscheduled material events or corporate changes. | 21 | 2018-06-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-04 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-18 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
